New Zealand markets close in 3 hours 53 minutes
  • NZX 50

    12,661.79
    -62.50 (-0.49%)
     
  • NZD/USD

    0.6817
    +0.0005 (+0.07%)
     
  • NZD/EUR

    0.6019
    +0.0008 (+0.13%)
     
  • ALL ORDS

    7,506.30
    -51.50 (-0.68%)
     
  • ASX 200

    7,191.60
    -44.30 (-0.61%)
     
  • OIL

    66.22
    +0.65 (+0.99%)
     
  • GOLD

    1,783.80
    -0.50 (-0.03%)
     
  • NASDAQ

    15,877.72
    -258.21 (-1.60%)
     
  • FTSE

    7,168.68
    +109.23 (+1.55%)
     
  • Dow Jones

    34,022.04
    -461.68 (-1.34%)
     
  • DAX

    15,472.67
    +372.54 (+2.47%)
     
  • Hang Seng

    23,658.92
    +183.66 (+0.78%)
     
  • NIKKEI 225

    27,935.62
    0.00 (0.00%)
     
  • NZD/JPY

    76.9410
    +0.1510 (+0.20%)
     

2021 Insights on the Ankylosing Spondylitis Global Market - Identify Target Patient Population - ResearchAndMarkets.com

·2-min read

The "Global Ankylosing Spondylitis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

This report provides Ankylosing Spondylitis epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Ankylosing Spondylitis patients, history of the disease at the population level (Ankylosing Spondylitis prevalence, Ankylosing Spondylitis incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Ankylosing Spondylitis patient flow: Ankylosing Spondylitis prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Ankylosing Spondylitis patients by age group, gender

  • Forecast: Ankylosing Spondylitis epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Ankylosing Spondylitis market sizing, assessing market potential, and developing drug forecast models

  • Identify Ankylosing Spondylitis patients segments through age groups, gender, and disease sub-types

  • Develop Ankylosing Spondylitis population-based health management frameworks

  • Evaluate Ankylosing Spondylitis market opportunities, identify target patient population

  • Align marketing decisions with the Ankylosing Spondylitis target population

  • Communicate leadership and health authorities about your Ankylosing Spondylitis target patient population

Key Topics Covered:

  1. Research Methodology

  2. Ankylosing Spondylitis Patients Definition

  3. US Ankylosing Spondylitis Epidemiology and Patient Flow

  4. Germany Ankylosing Spondylitis Epidemiology and Patient Flow

  5. France Ankylosing Spondylitis Epidemiology and Patient Flow

  6. Italy Ankylosing Spondylitis Epidemiology and Patient Flow

  7. Spain Ankylosing Spondylitis Epidemiology and Patient Flow

  8. UK Ankylosing Spondylitis Epidemiology and Patient Flow

  9. Europe Ankylosing Spondylitis Epidemiology and Patient Flow

  10. Japan Ankylosing Spondylitis Epidemiology and Patient Flow

  11. Global Ankylosing Spondylitis Epidemiology and Patient Flow

  12. Sources

For more information about this report visit https://www.researchandmarkets.com/r/ey20gi

View source version on businesswire.com: https://www.businesswire.com/news/home/20210513005497/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting